Continued advances in cell biology combined with access to broad multiomics data sets have shifted disease treatment from mass-market drugs to personalized precision medicines. We are taking this one step further to precision immune medicine, where we seek to harness the body’s own immune system to create safe cures for solid tumor cancers. Our technology platform vastly reshapes the discovery and development process by using multidimensional data that includes target, treatment, and patient selection to predict what treatments will work for specific patient groups.